SCHEMBL2912844

SCHEMBL2912844

COc1cccc(CC2(C(C(=O)NC3CCCCC3)C3CCCCC3)Nc3cc(F)c(F)cc3N2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
POLB P06746 1/20 0.48
PKM P14618 1/20 0.47
HTT P42858 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPK1 P28482 1/20 0.45
CASP1 P29466 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.42
NFKB1 P19838 1/20 0.41
CASP3 P42574 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2907076 0.92 LMNA (0.47) LMNAPOLBPKMHTTNPSR1
SCHEMBL3650592 0.87 SMN1; SMN2 (0.53) LMNAPOLBPKMHTTNPSR1
SCHEMBL2914994 0.86 MEN1 (0.48) LMNAPOLBNPSR1CYP3A4CYP2C19
SCHEMBL2912657 0.86 EPHX2 (0.51) LMNANPC1RAB9AKMT2AMEN1
SCHEMBL2909783 0.83 LMNA (0.46) LMNAHTTSMN1; SMN2ALDH1A1HSD17B10
SCHEMBL3650741 0.82 MAPT (0.47) LMNAPOLBSMN1; SMN2CYP1A2CYP3A4
SCHEMBL3648320 0.81 MEN1 (0.51) LMNASMN1; SMN2CYP1A2CYP3A4CYP2C19
SCHEMBL2907586 0.80 EPHX1 (0.41) SMN1; SMN2CYP3A4ALDH1A1NPC1RAB9A
SCHEMBL3650434 0.80 KMT2A (0.41) LMNASMN1; SMN2ALDH1A1NPC1RAB9A
SCHEMBL3654059 0.79 EPHX1 (0.44) LMNASMN1; SMN2ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed